Immunology and Uveitis

john kempen headshot

Systemic therapy outperforms intraocular implant for treating uveitis

May 6, 2017

After seven years, multi-center clinical trial finds systemic therapy better preserves visual acuity and has fewer side effects 

Boston, Mass. — Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better – and had fewer adverse outcomes – than a long-lasting corticosteroid intraocular implant, according to a clinical trial funded by the National Eye Institute (NEI). After seven years, visual acuity on average remained stable among participants on systemic therapy but declined by Read more about Systemic therapy outperforms intraocular implant for treating uveitis